COMP <GO>
KMTS vs XRAY // GROSS PROFIT MARGIN
Kestra Medical Technologies Ltd. (NASDAQ) VS. DENTSPLY SIRONA Inc. (NASDAQ) • 15-METRIC TALLY: KMTS 4
— XRAY 7
▲ GROSS PROFIT MARGIN LEADER: KMTS
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
gross-margins
51.40%
LAST: $9.61 (+1.80%) • MKT CAP: $1.92B
gross-margins
50.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KMTS VS. XRAY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KMTS | XRAY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 51.40% | 50.00% | +1.40 | KMTS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -11.00% | -24.00 | XRAY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.40% | 12.27% | -18.67 | XRAY | /fcf-yield <GO> |
| Operating Margin | -60.00% | -11.50% | -48.50 | XRAY | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -16.20% | -43.80 | XRAY | /net-margins <GO> |
| Revenue Growth (YoY) | 59.00% | -3.00% | +62.00 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 6.68% | -6.68 | XRAY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.65 | 0.45 | +9.20 | KMTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | XRAY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.5 | 55.1 | +2.47 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $1.92B | -$92.6M | XRAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KMTS REV | XRAY REV | KMTS GROSS % | XRAY GROSS % | KMTS FCF | XRAY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $95.1M | $3.68B | 51.4% | 50.0% | -$116.6M | $235.0M |
| FY 2024 | $59.8M | $3.79B | 40.5% | 51.6% | -$100.5M | $461.0M |
| FY 2023 | $27.8M | $3.96B | — | — | -$72.2M | $377.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KMTS // BETA —
XRAY // BETA —